Management of Acute Pancreatitis

Overview

1. Severity Classification (Revised Atlanta Criteria)

• BUN >25 mg/dL
• Impaired mental status
• SIRS (≥2 of 4 criteria)
• Age >60 years
• Pleural effusion on imaging

2. Initial Assessment and Triage

• All patients with suspected AP should be admitted to hospital
• Determine etiology early: serum triglycerides, calcium, LFTs, and abdominal ultrasound (gallstones - most common cause)
• Patients not responding to early resuscitation → step-down unit or ICU
• Patients with high BISAP, rising BUN/hematocrit, or established organ failure → direct ICU admission
• Consider early transfer to a tertiary pancreas center if multidisciplinary expertise is unavailable

3. Fluid Resuscitation

• Preferred fluid: Lactated Ringer's (LR) solution - shown to reduce systemic inflammation (lower CRP levels) compared to normal saline. The 2025 meta-analysis (PMID: 40085761) confirms LR is superior to saline for preventing progression to moderate-to-severe AP.
• Dosing (traditional aggressive strategy): 15-20 mL/kg bolus, then 2-3 mL/kg/h, targeting urine output >0.5 mL/kg/h
• Recent evidence: A newer RCT shows a less aggressive strategy (10 mL/kg bolus + 1.5 mL/kg/h) is not inferior and reduces fluid overload risk
• Monitoring: Hematocrit and BUN every 8-12 h; falling hematocrit and BUN within 12-24 h confirms adequate resuscitation
• A rising BUN during hospitalization correlates with inadequate hydration and higher mortality
• Use caution in elderly patients and those with cardiac or renal disease due to over-resuscitation risk

4. Analgesia

• IV narcotic analgesics for pain control (initiated early)
• Patient made NPO initially to reduce pancreatic stimulation
• Supplemental oxygen as needed
• Nasogastric tube not routinely required, but may be used for persistent vomiting

5. Nutritional Support

• Mild AP: Resume oral intake when the patient is hungry, has normal bowel function, and has no nausea/vomiting. Start with a low-fat solid diet (preferred over clear liquids)
• Moderate-Severe AP: Start enteral nutrition 2-3 days after admission
  • Enteral feeding maintains gut barrier integrity and reduces bacterial translocation
  • Nasogastric feeding is safe and acceptable; jejunal feeding offers theoretical benefits but is not definitively superior
• Parenteral nutrition (TPN): Reserved only when enteral goals cannot be met - it is more expensive, has more complications, and is not more effective than enteral feeding

6. Antibiotics

7. Imaging

• Abdominal ultrasound: First-line imaging on admission to assess for gallstones and biliary dilation
• CT scan with IV contrast: Indicated when patients are not responding to supportive care, not routinely within the first 72 h (overuse in early mild disease is common)
  • Best evaluated 3-5 days into hospitalization to assess necrosis and local complications
  • Reveals two types: interstitial (90-95%) and necrotizing (5-10%)
• MRI/MRCP: Alternative to CT, useful for ductal anatomy and pancreatic duct disruption
• Repeat CT/MRI with any change in clinical course (thrombosis, hemorrhage, abdominal compartment syndrome)

8. Special Etiology-Directed Management

Gallstone Pancreatitis

• ERCP within 24-48 h if ascending cholangitis (biliary obstruction + sepsis)
• ERCP within 72 h for severe gallstone pancreatitis or signs of cholangitis
• Cholecystectomy: Perform during the same admission in mild AP to prevent recurrence. In necrotizing AP, timing must be individualized.
• Patients unfit for surgery: endoscopic biliary sphincterotomy before discharge

Hypertriglyceridemia (TG >1000 mg/dL)

• IV insulin to treat hyperglycemia - typically corrects hypertriglyceridemia
• Keep patient fasting for 24-36 h initially (contrast to standard early feeding practice)

Hypercalcemia

• Treat underlying hyperparathyroidism or malignancy

Drug-Induced

• Discontinue the offending drug

Post-ERCP Pancreatitis (Prevention)

• Pancreatic duct stenting and/or rectal indomethacin reduces risk

9. Management of Local Complications

Necrosis (Necrotizing Pancreatitis)

• Presents with clinical deterioration, fever, leukocytosis, organ failure
• Fine-needle aspiration for culture is now used selectively (risk of contaminating sterile collections)
• Step-Up Approach (current standard):
  1. Step 1: Percutaneous catheter drainage (PCD) - effective alone in 1/3 to 1/2 of patients; regular exchange, upsizing, and irrigation improve success
  2. Step 2 (if PCD fails): Minimally invasive necrosectomy
     • Endoscopic transgastric drainage/necrosectomy - superior approach for walled-off necrosis (WON) near the stomach/duodenum (landmark RCT supports this)
     • Video-assisted retroperitoneal debridement (VARD) through a flank incision - reserved when WON is remote from stomach (e.g., left flank)
  3. Open surgery: Only when step-up approach fails or in rare abdominal compartment syndrome
• Timing of intervention: Delay to at least 3-4 weeks from onset to allow demarcation; early intervention carries higher risk of bleeding, disseminated infection, and collateral organ damage

Pseudocyst

• ~50% resolve spontaneously - conservative management initially
• Intervention indicated when: persistent pain, inability to eat, infection, or enlargement
• Communication with pancreatic duct is usually the reason for persistence
• Endoscopic or EUS-guided drainage preferred over surgery

Pancreatic Duct Disruption

• Presents as pancreatic ascites (high amylase in ascitic fluid) or enlarging fluid collection
• Diagnosed on MRCP or ERCP
• Bridging pancreatic stent for ≥6 weeks - >90% effective at resolving the leak
• Non-bridging stents less effective (25-50%); may be combined with TPN and octreotide

Perivascular Complications

• Splenic vein thrombosis with gastric varices, pseudoaneurysms, portal/SMV thrombosis
• Ruptured pseudoaneurysm: mesenteric angiography and embolization

10. Organ Failure Management (Severe/Critical AP)

• Admission to HDU/ICU
• Invasive hemodynamic monitoring (arterial line, CVP, urine output)
• Cardiovascular failure: Inotropic support (vasopressors)
• Respiratory failure: Supplemental O2 → high-flow → mechanical ventilation
• Renal failure: Hemofiltration/dialysis
• DIC: Coagulation support
• Multidisciplinary team: gastroenterology, surgery, interventional radiology, and intensivists

11. Monitoring and Follow-Up

• Frequent labs: CBC, BMP, LFTs, coagulation, serum calcium, blood glucose, triglycerides
• Monitor for hospital-acquired infections: pneumonia, UTI, line infections (occur in up to 20% of AP hospitalizations)
• Urine cultures, chest x-rays, and routine line changes
• Post-discharge: assess for new-onset diabetes mellitus, exocrine pancreatic insufficiency, recurrent cholangitis, or developing fluid collections
• About 25% of patients experience recurrence - investigate occult biliary disease, microlithiasis, hypertriglyceridemia, hereditary causes if recurrence is unexplained

Summary Algorithm

Suspected Acute Pancreatitis
       ↓
Confirm diagnosis (lipase/amylase >3x ULN) + Abdominal USS
       ↓
Severity assessment (BISAP, SIRS, APACHE II, Marshall score)
       ↓
Early aggressive IV fluids (LR preferred) + Analgesia + O2
       ↓
Mild AP ──────────────── NPO → early low-fat diet → Cholecystectomy if gallstone etiology
       ↓
Moderate-Severe/Severe AP
       ↓
HDU/ICU admission → Enteral nutrition at 2-3 days → No prophylactic antibiotics
       ↓
CT at 3-5 days if not improving
       ↓
Necrosis identified?
   Sterile → Conservative
   Infected → Step-up: PCD → Endoscopic/VARD necrosectomy → Surgery (last resort)
       ↓
Gallstone cause → ERCP (cholangitis/severe) → Cholecystectomy (timing per severity)

• Harrison's Principles of Internal Medicine, 22nd Edition (2025), pp. 2789-2793
• Schwartz's Principles of Surgery, 11th Edition, Chapter 33
• Bailey and Love's Short Practice of Surgery, 28th Edition, Chapter 72
• PMID: 40085761 - Zhao T et al. (2025) - Meta-analysis confirming LR superiority over saline in acute pancreatitis